Literature DB >> 11521982

Increased risk of developing atrophic gastritis in patients infected with CagA+ Helicobacter pylori.

N Sande1, M Nikulin, I Nilsson, T Wadström, F Laxén, M Härkönen, O Suovaniemi, P Sipponen.   

Abstract

BACKGROUND: To clarify the possible role of CagA positive (CagA+) Helicobacter pylori strains in the development of atrophic gastritis, the prevalence of antibodies to H. pylori and CagA (120 kD protein) was studied among subjects with atrophic and non-atrophic gastritis.
METHODS: The study population was randomly selected among 12,252 Finnish men who were screened for atrophic corpus gastritis with serum pepsinogen I-assay (S-PGI). S-PGI level was used as a selection criterion. Group A consisted of 295 subjects with S-PGI <25 microg/l (low), group B of 320 subjects with S-PGI 25-100 microg/l (normal) and group C of 338 subjects with S-PGI >100 microg/l (high). Antibodies to H. pylori were measured with EIA and immunoblot analysis and antibodies to CagA with immunoblot analysis. Endoscopical and histological examinations were performed for 203 patients from group A.
RESULTS: The prevalence of antibodies to H. pylori was significantly lower in group B than in groups A or C (P < 0.0001, chi-squared test). There was a significant association between the prevalence of antibodies to CagA and the lowered level of S-PGI (P < 0.0001, Jonckheere-Terpstra trend test). There was also a linear decrease in the prevalence of antibodies to CagA as the atrophic corpus gastritis became more severe (P < 0.0001, linear-by-linear trend test).
CONCLUSION: The presence of antibodies to CagA seems to be associated with development of atrophic corpus gastritis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11521982     DOI: 10.1080/003655201750305431

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

1.  Helicobacter pylori infection and atrophic gastritis.

Authors:  I A Ebule; A N Longdoh; I L Paloheimo
Journal:  Afr Health Sci       Date:  2013-03       Impact factor: 0.927

Review 2.  Approach to Helicobacter pylori infection in geriatric population.

Authors:  Sevdenur Cizginer; Zehra Ordulu; Abdurrahman Kadayifci
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

3.  Evaluation of a commercial immunoblot, Helicoblot 2.1, for diagnosis of Helicobacter pylori infection.

Authors:  Lea Veijola; Aino Oksanen; Pentti Sipponen; Hilpi Rautelin
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

4.  Transient and persistent Helicobacter pylori colonization in Native American children.

Authors:  Guillermo I Pérez-Pérez; R Bradley Sack; Raymond Reid; Mathuram Santosham; Janne Croll; Martin J Blaser
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

Review 5.  Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers.

Authors:  Lars Agréus; Ernst J Kuipers; Limas Kupcinskas; Peter Malfertheiner; Francesco Di Mario; Marcis Leja; Varocha Mahachai; Niv Yaron; Martijn van Oijen; Guillermo Perez Perez; Massimo Rugge; Jukka Ronkainen; Mikko Salaspuro; Pentti Sipponen; Kentaro Sugano; Joseph Sung
Journal:  Scand J Gastroenterol       Date:  2012-02       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.